Form 8-K - Current report:
SEC Accession No. 0001193125-23-098370
Filing Date
2023-04-12
Accepted
2023-04-12 06:04:36
Documents
12
Period of Report
2023-04-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d657301d8k.htm   iXBRL 8-K 39456
  Complete submission text file 0001193125-23-098370.txt   165800

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA veru-20230411.xsd EX-101.SCH 2848
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE veru-20230411_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE veru-20230411_pre.xml EX-101.PRE 11260
6 EXTRACTED XBRL INSTANCE DOCUMENT d657301d8k_htm.xml XML 3334
Mailing Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127
Business Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

EIN.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-13602 | Film No.: 23814560
SIC: 2834 Pharmaceutical Preparations